Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: zurdo who wrote (4991)	8/18/1998 12:42:00 PM
From: flickerful	Read Replies (1) \| Respond to of 9523

zurdo... a purple haze of buyers, perhaps has bullied the options crowd? wouldn't that be terrible? hmm.

To: zurdo who wrote (4991)	8/18/1998 12:53:00 PM
From: LWolf	Read Replies (1) \| Respond to of 9523

zurdo... someone is buying.... L

To: zurdo who wrote (4991)	8/18/1998 12:56:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Thailand Grants Final Approval For Import Of Viagra August 18, 1998 11:28 AM BANGKOK (AP)--Thailand's Food and Drug Administration has given final approval for the import of the new impotence drug Viagra, agency officials said Tuesday. Pfizer (PFE), the maker of Viagra, applied for FDA approval in February. Since then, a black market has developed for the drug, with a single pill selling for about $30. Thai media also reported last week that local counterfeiters are producing fake Viagra pills composed primarily of flour, and selling them for the same price as the real ones. Authorities have seized more than 150 fake tablets. The go-ahead to import Viagra should help diminish the black market, FDA officials said. Under FDA rules, Viagra won't be available in drug stores, but will be sold only in hospital pharmacies with a prescription from either a urologist, cardiologist, endocrinologist or psychiatrist. The pill will be priced at $10 each, the same as in the U.S. Mongkol na Songkhla, secretary general of the FDA, estimated in June that there are about 100,000 Thais who qualify for prescriptions. He said the FDA will continue to monitor the drug after its approval because of questions about its safety. smartmoney.com